Caspase activation is involved in early megakaryocyte differentiation but not in platelet production from megakaryocytes

Leukemia

Volumn 23, Issue 6, 2009, Pages 1080-1086

  Kozuma, Y ^a   Yuki, S ^a   Ninomiya, H ^a   Nagasawa, T ^a,b   Kojima, H ^a,c  

^a UNIVERSITY OF TSUKUBA   (Japan)

^b Tsukuba Memorial Hospital   (Japan)

^c IBARAKI PREFECTURAL CENTRAL HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ATAXIN 1; CASPASE; CD34 ANTIGEN; FLUOROURACIL; PROTEIN BCL 2; STEM CELL FACTOR RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL DIFFERENTIATION; CELL LINEAGE; CONTROLLED STUDY; ENZYME ACTIVATION; ERYTHROID PRECURSOR CELL; HEMATOPOIETIC STEM CELL; IN VITRO STUDY; IN VIVO STUDY; MEGAKARYOCYTE; MEGAKARYOPOIESIS; MOUSE; NONHUMAN; PLOIDY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SPLENECTOMY; THROMBOCYTE COUNT; THROMBOCYTOPENIA; THROMBOCYTOPOIESIS; TRANSGENIC MOUSE; WILD TYPE;

EID: 67349153739     PISSN: 08876924     EISSN: 14765551     Source Type: Journal    
DOI: 10.1038/leu.2009.7     Document Type: Article

References (23)

1. Shivdasani RA. Molecular and transcriptional regulation of megakaryocyte differentiation. Stem Cells 2001; 19: 397-407.
2. Pang L, Weiss MJ, Poncz M. Megakaryocyte biology and related disorders. J Clin Invest 2005; 115: 3332-3338.
3. Italiano Jr JE, Lecine P, Shivdasani RA, Hartwig JH. Blood platelets are assembled principally at the ends of proplatelet processes produced by differentiated megakaryocytes. J Cell Biol 1999; 147: 1299-1312.
4. Junt T, Schulze H, Chen Z, Massberg S, Goerge T, Krueger A et al. Dynamic visualization of thrombopoiesis within bone marrow. Science 2007; 317: 1767-1770.
5. Italiano JE, Hartwig JH. Megakaryocyte development and platelet formation. In: Michelson AD (ed). Platelets 2nd edn. Academic Press: Burlington, MA, 2007, pp 23-44.
6. Zauli G, Vitale M, Falcieri E, Gibellini D, Bassini A, Celeghini C et al. In vitro senescence and apoptotic cell death of human megakaryocytes. Blood 1997; 90: 2234-2243.
7. + progenitors but is absent from senescent megakaryocytes. Exp Hematol 2001; 29: 728-735.
8. Clarke MC, Savill J, Jones DB, Noble BS, Brown SB. Compartmentalized megakaryocyte death generates functional platelets committed to caspase-independent death. J Cell Biol 2003; 160: 577-587.
9. De Botton S, Sabri S, Daugas E, Zermati Y, Guidotti JE, Hermine O et al. Platelet formation is the consequence of caspase activation within megakaryocytes. Blood 2002; 100: 1310-1317.
10. Kaluzhny Y, Yu G, Sun S, Toselli PA, Nieswandt B, Jackson CW et al BclxL overexpression in megakaryocytes leads to impaired platelet fragmentation. Blood 2002; 100: 1670-1678.
11. Kozuma Y, Kojima H, Yuki S, Suzuki H, Nagasawa T. Continuous expression of Bcl-xL protein during megakaryopoiesis is posttranslationally regulated by thrombopoietin-mediated Akt activation, which prevents the cleavage of Bcl-xL. J Thromb Haemost 2007; 5: 1274-1282.
12. Lamkanfi M, Festjens N, Declercq W, Vanden Berghe T, Vandenabeele P. Caspases in cell survival, proliferation and differentiation. Cell Death Differ 2007; 14: 44-55.
13. Carlile GW, Smith DH, Wiedmann M. Caspase-3 has a nonapoptotic function in erythroid maturation. Blood 2004; 103: 4310-4316.
14. Zermati Y, Garrido C, Amsellem S, Fishelson S, Bouscary D, Valensi F et al. Caspase activation is required for terminal erythroid differentiation. J Exp Med 2001; 193: 247-254.
15. Ogilvy S, Metcalf D, Print CG, Bath ML, Harris AW, Adams JM. Constitutive Bcl-2 expression throughout the hematopoietic compartment affects multiple lineages and enhances progenitor cell survival. Proc Natl Acad Sci USA 1999; 96: 14943-14948.
16. Pronk CJ, Rossi DJ, Månsson R, Attema JL, Norddahl GL, Chan CK et al. Elucidation of the phenotypic, functional, and molecular topography of a myeloerythroid progenitor cell hierarchy. Cell Stem Cell 2007; 1: 428-442.
17. Kojima H, Moroi M, Jung SM, Goto S, Tamura N, Kozuma Y et al. Characterization of a patient with glycoprotein (GP) VI deficiency possessing neither anti-GPVI autoantibody nor genetic aberration. J Thromb Haemost 2006; 4: 2433-2442.
18. Zinkel S, Gross A, Yang E. BCL2 family in DNA damage and cell cycle control. Cell Death Differ 2006; 13: 1351-1359.
19. Sordet O, Rébé C, Plenchette S, Zermati Y, Hermine O, Vainchenker W et al. Specific involvement of caspases in the differentiation of monocytes into macrophages. Blood 2002; 100: 4446-4453.
20. Kolbus A, Pilat S, Husak Z, Deiner EM, Stengl G, Beug H et al. Raf-1 antagonizes erythroid differentiation by restraining caspase activation. J Exp Med 2002; 196: 1347-1353.
21. Launay S, Hermine O, Fontenay M, Kroemer G, Solary E, Garrido C. Vital functions for lethal caspases. Oncogene 2005; 24: 5137-5148.
22. Fernando P, Kelly JF, Balazsi K, Slack RS, Megeney LA. Caspase 3 activity is required for skeletal muscle differentiation. Proc Natl Aca Sci USA 2002; 99: 11025-11030.
23. Sun S, Ravid K. Role of a serine/threonine kinase, Mst1, in megakaryocyte differentiation. J Cell Biochem 1999; 76: 44-60.